欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
DK/H/3036/001
药品名称
Fluticasonpropionat "Teva"
活性成分
fluticasone 50.0 µg
剂型
Nasal spray*
上市许可持有人
Teva B.V. Swensweg 5 2031 GA Haarlem Holland
参考成员国 - 产品名称
Denmark (DK)
互认成员国 - 产品名称
Norway (NO)
Flutikason Teva
United Kingdom (Northern Ireland) (XI)
Germany (DE)
Ireland (IE)
Spain (ES)
Portugal (PT)
Finland (FI)
Poland (PL)
Hungary (HU)
Czechia (CZ)
Slovakia (SK)
许可日期
2008/04/05
最近更新日期
2023/01/03
药物ATC编码
R01AD08 fluticasone
申请类型
TypeLevel1：
[not specified]
TypeLevel2：
[not specified]
TypeLevel3：
[not specified]
TypeLevel4：
[not specified]
TypeLevel5：
[not specified]
附件文件下载
Final PL
|
Fluticasone_DK_H_3036_001_PIL_consolidated_clean
Date of last change:2023/02/28
Final SPC
|
Fluticasone_DK_H_3036_001_SmPC_konsolidated_clean
Date of last change:2023/02/28
Final Labelling
|
Fluticasone_DK_H_3036_001_OuP_30_05_22_clean
Date of last change:2022/09/07
Final Labelling
|
Fluticasone_DK_H_3036_001_ImP_30_05_22_clean
Date of last change:2022/09/07
Final Product Information
|
Fluticasone_DK_H_3036_001_SmPC_29_08_22_clean
Date of last change:2022/09/07
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase